Binding of von Willebrand factor to collagen and glycoprotein Ibalpha, but not to glycoprotein IIb/IIIa, contributes to ischemic stroke in mice--brief report.

Simon F De Meyer, Tobias Schwarz, Hans Deckmyn, Cécile V Denis, Bernhard Nieswandt, Guido Stoll, Karen Vanhoorelbeke, Christoph Kleinschnitz

Laboratory for Thrombosis Research, KULeuven Campus Kortrijk, E Sabbelaan 53, B-8500 Kortrijk, Belgium.

Journal Article: Arteriosclerosis Thrombosis and Vascular Biology (impact factor: 7.24). 10/2010; 30(10):1949-51. DOI: 10.1161/ATVBAHA.110.208918

Abstract

To unravel crucial von Willebrand factor (VWF) interactions that are detrimental in stroke development.
VWF(-/-) mice received gene transfer to express mutants of VWF defective either in binding to fibrillar collagen, glycoprotein (GP)Ibα or GPIIb/IIIa, and underwent 60 minutes of transient middle cerebral artery occlusion. In VWF(-/-) mice reconstituted with VWF mutants defective in binding to collagen or GPIbα, protection against stroke was sustained, whereas VWF lacking the GPIIb/IIIa binding site restored full susceptibility similar to normal VWF.
VWF-collagen and VWF-GPIbα (but not VWF-GPIIb/IIIa) interactions are instrumental in thrombus formation after transient middle cerebral artery occlusion, and their inhibition could be a promising target for stroke treatment.

Source: PubMed

Comments on this publication

ResearchGate members can add comments. Sign up now and post your comment!

Similar publications

Science & Research Jobs

Keywords

60 minutes
 
binding
 
collagen
 
fibrillar collagen
 
full susceptibility
 
gene transfer
 
glycoprotein
 
GPIbα
 
GPIIb/IIIa
 
GPIIb/IIIa binding site
 
mutants
 
promising target
 
thrombus formation
 
transient middle cerebral artery occlusion
 
unravel crucial von Willebrand factor
 
VWF mutants defective
 
VWF-collagen
 
VWF-GPIbα
 
VWF-GPIIb/IIIa